Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 2 medicines
CBG-MEB · 1 medicine
TFDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cloridrato de Nalbufina | Brazil | Authorised | Hipolabor Farmaceutica Ltda | ||
| Nalbli | Brazil | Authorised | Halex Istar Indústria Farmacêutica SA | ||
| Nubain | Brazil | Authorised | Cristália Produtos Químicos Farmacêuticos Ltda. | ||
| Nalfina | Brazil | Cancelled | Produtos Farmacêuticos Gunther do Brasil Ltda | ||
| Naufen | Brazil | Cancelled | Eurofarma Laboratorios S.A. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of Anvisa, CBG-MEB, FDA, Health Canada and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
